Dasatinib is an inhibitor of multiple tyrosine kinases. It is marketed as Sprycel for the treatment of chronic myeloid leukemia (CML). It is also indicated for the treatment of adults with Philadelphia chromosome- positive acute lymphoblastic leukemia.
Related categories 1
Sites 1
- RxList: Sprycel (Dasatinib) Information about the drug includes description, dosage, administration, and treatment indications.